What to Expect During an IV Infusion Session Sessions typically last 4590 minutes Infusions are administered by trained infusion RNs Patients are monitored throughout the session Frequency may be weekly, biweekly, or monthly , depending on goal Our infusion suite is designed to be calming, comfortable, and supportivehelping patients feel at ease during treatment
J Basic Clin Pharm
SURMOUNT-3 and SURMOUNT-4 Trials (2023) In a 2023 NEJM publication , researchers reported that Retatrutide: Produced an average of 24.2% total body weight loss at 48 weeks in individuals without diabetes Patients on the highest dose lost over 58 pounds on average Outperformed all currently available GLP-1 and GIP analogs Additional findings included: Significant reduction in liver fat (up to 85%) Improved insulin sensitivity and HOMA-IR scores Reduced blood pressure, triglycerides, and inflammation markers These results are unmatched in obesity pharmacotherapy history and suggest that Retatrutide could soon set a new gold standard for metabolic treatment
Rizzuti M, Filosa G, Melzi V, Calandriello L, Dioni L, Bollati V, et al